Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the opening of a new office in Wilmington, North Carolina.
 

According to Emmes Chief Executive Officer Dr. Christine Dingivan, “Wilmington is a center for clinical research innovation, and creating this new office will encourage even more collaboration and idea-sharing among our employees in the area. We are thrilled to expand our presence in a community viewed as an incubator for the CRO industry.”

Mergers & Acquisitions (M&A) Expertise Adds Value to Emmes’ Growth  Plans

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Matt Honan has joined the company as vice president and global head of corporate development.

New COO Adds International Experience and Clinical Operations Depth to Emmes’ Portfolio
 

Rockville, MD, December 15, 2022 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Wendy Buckland will join the company as its chief operating officer, leading global operations.

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Ching Tian has joined the company as chief innovation officer.
 

Decades of Experience and Emerging Opportunities Led to its Creation.
 

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.

Global CRO’s India office reports surging growth from Western, regional and local trial customers
 

VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the acquisition of VaxTRIALS. Headquartered in Panama City, Panama, VaxTRIALS’ 160+ staff members manage and monitor vaccine clinical trial activities throughout Latin America.

His M&A Background and Experience with Successful Private-Equity-Backed Companies Will Benefit the Company’s Growth and Diversification Strategy 

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Matt Bond has become its chief financial officer (CFO). 

Christine McSherry is a Presenter at a Major Clinical Trials Conference

Dr. Kondru Brings a Formidable Blend of Scientific Expertise and Visionary Technology and Data Sciences Leadership Background to Lead the Emmes Group’s New Technology and Artificial Intelligence (AI) Business
    
The Emmes Group today announced that its newly launched Veridix AI business will be led by Dr. Rama Kondru as its’ Chief Executive Officer.